PROTAC BRD4 Degrader-11
Partner: MedChemexpress LLC
Applications: | Cancer-programmed cell death |
MW: | 1292.56 |
Formula: | C61H75F2N9O12S4 |
SMILES: | CC(N=CS1)=C1C2=CC=C(CNC([C@@H]3C[C@H](CN3C([C@@H](NC(CCCCCCCCCCNC(C4=CC(N(C5=NC=C(F)C=C5F)CC6=CNC7=C6C8=CN(C)C7=O)=C8C=C4CS(=O)(C)=O)=O)=O)C(C)(C)C)=O)OC(OC[C@@H](C)SS(C)(=O)=O)=O)=O)C=C2 |
Purity: | 99.45 |
Description: | PROTAC BRD4 Degrader-11 (compound 9a) is a PROTAC connected by ligands for von Hippel-Lindau and BRD4. PROTAC BRD4 Degrader-11 can be conjugated with STEAP1 and CLL1 antibodies to degrade the BRD4 protein in PC3 prostate cancer cells, with a DC50 of 0.23 nM and 0.38 nM, respectively[1]. |
Shipping Conditions: | Ship on cold packs |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice